Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Am J Gastroenterol. 2021 Dec 1;116(12):2446–2454. doi: 10.14309/ajg.0000000000001527

Table 4a:

Estimated acute pancreatitis rates per 1,000 patient-years from multivariable model* incorporating full study population (n=10,417)

Pancreas Sufficient
Cystic Fibrosis (PS-CF)
Pancreas Insufficient
Cystic Fibrosis (PI-CF)
On CFTR Modulator, AP per 1000 patient years (95% CI) 3.26 (0.94, 11.33) 0.66 (0.26, 1.68)
Not on CFTR Modulator, AP per 1000 patient years (95% CI) 10.20 (6.19, 16.81) 1.76 (0.98, 3.17)
*

Adjusted for age, sex, Charlson comorbidity index, and geographic region

Acute pancreatitis (AP)